Cynapsus Therapeutics Company
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson–≤–Р–©s disease.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Canada
Founded Date:
2004
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
3
Total Funding:
$23.8M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership